Meanwhile, Enho mutations and adropin-deficiency were found in patients with FP and T2DM, which revealed the two diseases share similar pathogenetic mechanisms and multiple metabolic derangements which can accelerate the development and progression of both conditions. This evidence concerns the gene ENHO and hyperinsulinemic hypoglycemia, familial, 4.